ResearchMoz

Orthostatic Hypotension Global Clinical Trials Review, H1, 2012

Publisher Name » GlobalData
Published Date » 2012-05-21
No. Of Pages » 111


GlobalData's clinical trial report, Orthostatic Hypotension Global Clinical Trials Review, H1, 2012" provides data on the Orthostatic Hypotension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Orthostatic Hypotension . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Orthostatic Hypotension . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords

Orthostatic Hypotension Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Orthostatic Hypotension , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5

Introduction 6
Orthostatic Hypotension 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Nations 14
Clinical Trials in G7 Nations by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Unaccomplished Trials of Orthostatic Hypotension 19
Subjects Recruited Over a Period of Time 20
Prominent Sponsors 21
Top Companies Participating in Orthostatic Hypotension Therapeutics Clinical Trials 23
Prominent Drug Comparison 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Chelsea Therapeutics International Ltd. 26
Clinical Trial Overview of Chelsea Therapeutics International Ltd. 26
Shire Plc 27
Clinical Trial Overview of Shire Plc 27
Mylan Pharmaceuticals Inc. 28
Clinical Trial Overview of Mylan Pharmaceuticals Inc. 28
Mylan Inc. 29
Clinical Trial Overview of Mylan Inc. 29
Menarini International O.L.S.A 30
Clinical Trial Overview of Menarini International O.L.S.A 30
Shire Pharmaceutical Development Inc. 31
Clinical Trial Overview of Shire Pharmaceutical Development Inc. 31
Shire Laboratories, Inc. 32
Clinical Trial Overview of Shire Laboratories, Inc. 32
Oy Juvantia Pharma Ltd. (Inactive) 33
Clinical Trial Overview of Oy Juvantia Pharma Ltd. (Inactive) 33
Clinical Trial Overview of Top Universities / Institutes / Hospitals 34
Vanderbilt University 34
Clinical Trial Overview of Vanderbilt University 34
Mayo Clinic 35
Clinical Trial Overview of Mayo Clinic 35
Royal Brisbane and Women's Hospital 36
Clinical Trial Overview of Royal Brisbane and Women's Hospital 36
Mount Sinai School of Medicine 37
Clinical Trial Overview of Mount Sinai School of Medicine 37
The University of British Columbia 38
Clinical Trial Overview of The University of British Columbia 38
Sheba Medical Center 39
Clinical Trial Overview of Sheba Medical Center 39
Tel-Aviv Sourasky Medical Center 40
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 40
Assaf-Harofeh Medical Center 41
Clinical Trial Overview of Assaf-Harofeh Medical Center 41
Cedars-Sinai Medical Center 42
Clinical Trial Overview of Cedars-Sinai Medical Center 42
Five Key Clinical Profiles 43

Appendix 108
Abbreviations 108
Definitions 108
Research Methodology 109
Secondary Research 109
About GlobalData 110
Contact Us 110
Disclaimer 110
Source 111

List of Tables

 
Orthostatic Hypotension Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
Orthostatic Hypotension Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Orthostatic Hypotension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Orthostatic Hypotension Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10
Orthostatic Hypotension Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11
Orthostatic Hypotension Therapeutics Clinical Trials, North America, Top Countries, 2012* 12
Orthostatic Hypotension Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13
Orthostatic Hypotension Therapeutics Clinical Trials, G7 Countries, 2012* 14
Orthostatic Hypotension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15
Orthostatic Hypotension Therapeutics Market, Global, Clinical Trials by Phase, 2012* 16
Orthostatic Hypotension Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 17
Orthostatic Hypotension Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 18
Orthostatic Hypotension Therapeutics Market, Global, Terminated Clinical Trials, 2012* 19
Orthostatic Hypotension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 20
Orthostatic Hypotension Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 22
Orthostatic Hypotension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 24
Orthostatic Hypotension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 25
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Chelsea Therapeutics International Ltd., 2012* 26
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2012* 27
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Pharmaceuticals Inc., 2012* 28
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Inc., 2012* 29
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Menarini International O.L.S.A, 2012* 30
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Pharmaceutical Development Inc., 2012* 31
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Laboratories, Inc., 2012* 32
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Oy Juvantia Pharma Ltd. (Inactive), 2012* 33
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2012* 34
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 35
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Brisbane and Women's Hospital, 2012* 36
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai School of Medicine, 2012* 37
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of British Columbia, 2012* 38
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba Medical Center, 2012* 39
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2012* 40
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Assaf-Harofeh Medical Center, 2012* 41
Orthostatic Hypotension Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2012* 42

List of Figures

List of Figures

Orthostatic Hypotension Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
Orthostatic Hypotension Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Orthostatic Hypotension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Orthostatic Hypotension Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10
Orthostatic Hypotension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11
Orthostatic Hypotension Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12
Orthostatic Hypotension Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 13
Orthostatic Hypotension Therapeutics Clinical Trials, G7 Countries (%), 2012* 14
Orthostatic Hypotension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15
Orthostatic Hypotension Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 16
Orthostatic Hypotension Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 17
Orthostatic Hypotension Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 18
Orthostatic Hypotension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 20
Orthostatic Hypotension Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 21
Orthostatic Hypotension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 23
Orthostatic Hypotension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 25
GlobalData Methodology 109

Upcoming Reports:

Medical Education Market: Global Industry Analysis, Size, Share And Forecast, 2012 - 2018
By - Transparency Market Research
Medical education is the term associated with the practice of working as a medical practitioner either for initial training to become a doctor or for additional training after gaining the degree. Medical education market actors includemedical schools, health program providers, nursing programs providers, and such others. Continuous growth in world population and rising awareness towards personal health is creating the need for seeking medical education, either for working as a medical practitioner or for personal care.  Global market for medical education is on...
Psoriatic Arthritis Pharmacotherapy Market - Global Industry Analysis, Size, Share And Forecast, 2012 - 2018
By - Transparency Market Research
Psoriatic Arthritis is a type of rheumatoid arthritis which mainly affects fingers and toes followed by psoriasis. Moreover, a condition in which person has both psoriasis and arthritis is identified to have suffered from psoriatic arthritis. Major symptom for psoriatic arthritis is associated with inflammation of the skin and joints. About 11% of patients who has psoriatic also develop inflammation of their joints in a time frame ranging from 6 months to 1 year or sometimes even more, depending upon the personality of the patient.  The global psoriatic arthritis...
Palm Oil Market - Global Industry Analysis, Size, Market Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Palm oil is one of the most commonly consumed edible oils and is extracted from the fruit of the palm tree. It has comparatively low cost and does not have any trans fat, making it ideal for use in the food industry. India, Indonesia, and China are the major consumers of palm oil in the world and with the growth in emerging economies, the demand for this oil is expected to grow. Palm oil based on type is segregated into palm oil, palm kernel oil and others. It is used in applications like food, health, energy and others, which includes cosmetics. One of the focuses of the...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...